Objective: To review published data on vascular disease-and diabetes-related outcomes related to adiposity and metabolic risk factors. Design: Community cohort study with cross-sectional and prospective data. Subjects: Middle-aged Caucasian adults in a suburban environment. Measurements: Traditional risk factors for cardiovascular disease and the type 2 diabetes mellitus, as well as measures of insulin resistance, left ventricular hypertrophy and vascular calcification. Results: The cardiometabolic risk factors cluster in the population and a common core that includes adiposity (both waist and body mass index), abnormal lipids (both HDL cholesterol and triglycerides), and abnormal glucose and insulin metabolism was found to be present in Framingham participants. Increased insulin resistance was also found to be associated with coronary artery calcification and left ventricular hypertrophy in women. Analyses of the metabolic syndrome risk factors showed that a greater burden of risk factors was associated with greater risk of both cardiovascular disease and diabetes mellitus. An equation to estimate risk of developing type 2 diabetes mellitus has been developed from the Framingham experience, and the risk factors included in the metabolic syndrome are key components, including increased waist girth, elevated blood pressure, low HDL cholesterol, high triglycerides and impaired fasting glucose. Conclusion: Cardiometabolic factors and insulin resistance are important contributors to the development of type 2 diabetes mellitus, subclinical cardiovascular disease and clinical cardiovascular disease.
Introduction
Several risk factors increase the risk of both cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM), and the term cardiometabolic risk has been used to describe this phenomenon. The key factors are the components of the metabolic syndrome, and excess adiposity is usually the key factor that underlies their occurrence. This article reviews evidence concerning the prevalence and effects of the metabolic syndrome, insulin resistance and cardiometabolic abnormalities as determinants of risk for the development of heart disease and T2DM in the experience of the Framingham Offspring participants.
Methods
The data reviewed here include published findings reported for the Framingham Heart Study Offspring participants. This population sample of 5135 men and women was first examined in 1971 and has been followed since that time with regular clinic visits and surveillance for the development of coronary heart disease (CHD) and T2DM. At examination 5 that took place from 1991 to 1995, the participants underwent oral glucose tolerance testing with insulin measurements, which allowed for characterization of glycemic status and provided especially detailed metabolic factor data that have been used in studies related to the metabolic syndrome, insulin resistance, occurrence of subclinical vascular disease, and the development of clinical heart disease and new T2DM.
1 Follow-up has included fasting glucose measurements at the time of follow-up clinic examinations that occurred 4 and 8 years after the baseline, along with surveillance for the occurrence of new vascular events and diabetes mellitus.
Results and discussion
Risk factors cluster in the population and earlier analyses in Framingham Offspring showed that adiposity and weight gain were key determinants of the degree of metabolic risk factor clustering. Cardiometabolic risk factor clustering in Framingham participants was analyzed more formally with principal components analyses in a report by Meigs.
3 These results
were consistent with more than one independent physiological process underlying risk variable clustering: a central metabolic syndrome (characterized by hyperinsulinemia, dyslipidemia and obesity), glucose intolerance, and hypertension. Glucose intolerance and hypertension were linked to the central syndrome through shared correlations with insulin levels and obesity. The presence of the central syndrome with overlap for the glucose intolerance and hypertension components is shown in Figure 1 . Other Framingham investigations have focused on the role of insulin resistance on subclinical disease, and the authors found in cross-sectional studies that greater insulin resistance was associated with increased left ventricular mass in women and with greater coronary artery calcification in both sexes. 4, 5 The metabolic syndrome became a popular term in the medical literature after the publication of the National Cholesterol Education Program guidelines in 2001, in which they identified criteria such as waist girth, HDL cholesterol, triglycerides, blood pressure and fasting glucose as metabolic factors that would help physicians to identify persons at greater risk of developing CVD. 6 The presence of the metabolic syndrome was defined as the presence of three or more of the five traits. (Table 1) . 10 A sensitivity analysis according to the number of risk factors present and to whether impaired fasting glucose was present showed that having either two or three of the five metabolic trait risk factors generally doubled CVD risk and had a greater effect on T2DM risk. The most striking increased risk for T2DM was observed in persons with impaired fasting glucose and with the concomitant presence of cardiometabolic risk factors, as shown in Table 2 , which summarizes many analyses concerning the relative effects of different trait clusters. 10 Analyses that used the presence of zero metabolic risk factors as the comparator showed that the risk of vascular events increased significantly even with one or two metabolic risk factor traits, and that having three or more of the five metabolic traits led to very large increases in CVD risk and T2DM risk (Table 3) . A recent publication that analyzed the determinants of incident T2DM in the Framingham Offspring showed that the incidence of new T2DM can be estimated with good discrimination.
11 Table 4 shows the results of a recent (not statistically significant) and parental history of diabetes mellitus (statistically significant), as shown in Table 4 . With the variables in the simple clinical model, it is possible to estimate the risk of incident T2DM with this approach. This approach can help to predict risk of new diabetes over a 7-year interval and needs to be tested in other locales with other population samples at risk to develop diabetes mellitus. The presence of multiple metabolic traits, especially elevated fasting plasma glucose, acts synergistically to increase future risk of developing T2DM in this situation. In summary, several factors act in concert and underlie the pathogenesis of both T2DM and CVD, including high triglycerides, elevated glucose and low HDL cholesterol. Excess adiposity, especially abdominal adiposity, and insulin resistance are probably key ingredients that lead to the development of the risk factor abnormalities that then translate into the clinical outcomes. Interventions that target both the risk factors and the underlying conditions that lead to the risk factors ought to be effective preventive strategies to reduce the risk of CVD and diabetes mellitus in adults.
